Erratum: Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study): Erratum.

[This corrects the article DOI: 10.1097/MD.0000000000004949.].

In the article “Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study)”,[ which appeared in Volume 95, Issue 40 of Medicine, Figure 1a originally appeared incorrectly. The figure should have appeared as follows:

In addition, the final sentence of the first paragraph of section 3.2, Maternal Outcomes, should have read as follows:

The pooled analysis used the random-effects model as the I2 was 87% (high-heterogeneity) and demonstrated significant difference in improving maternal pruritis by UDCA compared with control groups (RR 1.58, 95% CI 1.09—2.28, P < 0.05).